Andrews Syndrome

Andrews syndrome is a rare genetic disease that is characterized by damage to the nervous system, dysfunction of muscles and organs, and metabolic disorders.

The syndrome was discovered in 1964 by American dermatologist George Andrews, who described a patient with this disease. Andrews found that the patient had muscle weakness and impaired nerve function, as well as other symptoms such as decreased appetite, metabolic problems and low blood sugar.

It is now known that Andrews syndrome is the result of a mutation in a gene that is responsible for the production of a protein necessary for normal development of the nervous system. The mutation disrupts the function of this protein and causes a variety of symptoms, including muscle weakness, impaired nerve function and other problems.

Treatment for Andrews syndrome includes medications that can help improve nervous system function and metabolism. However, because the disease is rare, treatment can be difficult and patients may require specialist care and medical support throughout their lives.

**Andrews syndrome** is a rare genetic syndrome in which patients experience phenotypic changes, manifested by an abnormality in the cerebral vessels, they lose elasticity and their walls thicken. Violations of vascular tone lead to an abnormal increase in blood pressure in them and can lead to strokes. The syndrome was first discovered by the American doctor Andrews in 1950. During the examination of the patient, he discovered areas of soft tissue on the neck and back of the head that looked like pustules. Most often, the syndrome is accompanied by abnormal hair loss with the manifestation of amputations of hair shafts. The patient experiences beard hair loss, thinning, as well as seborrhea of ​​the scalp - the appearance of keratinized scales and dandruff on it. There are also a number of symptoms associated with the syndrome: muscle weakness, increased muscle fatigue, diffuse atrophic visual impairment. One of the most characteristic manifestations of the syndrome is considered to be vasomotor rhinitis - chronic inflammation of the mucous membranes of the nose. Vasomotor rhinitis manifests itself in the form of difficulty in nasal breathing (when sneezing, the patient feels